Swiss Initiative To Monitor Missing Medical Devices To Manage Current Product Crisis
The ongoing availability of many medical devices in Switzerland is threatened even more severely than in the EU. Medtech Insight spoke to two key life science experts to understand why this is and to hear the solutions they are proposing.
You may also be interested in...
Do all roads lead back to the reopening of the Medical Device Regulation and risk-based staggered delays as was introduced with the IVD Regulation? Medtech Insight spoke to TÜV SÜD’s Dr Royth von Hahn and BSI’s Graeme Tunbridge, about how potential solutions to MDR delays are being received.
The Swiss medtech market is now served by 1,200 companies fewer than when its MRA with the EU was still in force. A renewal of the agreement is not a lost hope for the local industry, but at present it is a distant prospect.
All eyes were on the European Commission in January as it edged closer to adopting new legislation that will see the Medical Device Regulation transition deadlines extended.